Does PALBOCICLIB Cause Metastasis? 99 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 99 reports of Metastasis have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
99
Reports of Metastasis with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
16
Deaths
16
Hospitalizations
How Dangerous Is Metastasis From PALBOCICLIB?
Of the 99 reports, 16 (16.2%) resulted in death, 16 (16.2%) required hospitalization, and 5 (5.1%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 99 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
Which PALBOCICLIB Alternatives Have Lower Metastasis Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID